Lumo BodyTech, Inc
USPTO PatentsView assignee record - 8 granted patents across 4 technology areas, recorded in grant years 2015–2018. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Lumo ranks #32,385 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 4 technology areas.
- #32,385
- of 49,997 US assignees by volume
- 15th percentile
- by Innovation Score (24.7/100)
- 16.8
- avg claims per patent
- -100%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R32385 · US Corporation #32,385 · 8 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 8 grants
- MID-PACK #32,385/49,997
- PHOTO-FINISH Louver-Lite
- CPC-NARROW A61B · 4 areas
- INNOV-THIN 24.7/100
- CLAIMS-RICH 16.8 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -100% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Louver-Lite Limited (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Lumo’s 24.7 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Lumo
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Lumo BodyTech · this assignee 25
Lumo BodyTech · this assignee
25 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Lumo's Innovation Score is 24.7/100 (15th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Lumo?
Each dot is one of Lumo’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Lumo’s own 16.8 claims/patent is ABOVE the 8.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Lumo's grants concentrate
Lumo BodyTech, Inc is a focused PatentsView assignee: 4 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). By volume, Lumo sits between Louver-Lite Limited and M Group, Inc..
Who files at Lumo's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Louver-lite
Louver-Lite Limited
8 patents
- Lucase3 L C
LucasE3, L.C.
8 patents
- Lucerno Dynamics
Lucerno Dynamics, LLC
8 patents
- Lucida Research
Lucida Research LLC
8 patents
- Lundbeck Pharmace…
Lundbeck Pharmaceuticals Italy S.P.A.
8 patents
- Lutz Pumpen
Lutz Pumpen GmbH
8 patents
- Luxer
Luxer Corporation
8 patents
- M Group
M Group, Inc.
8 patents
- Lumo Bodytech ◀
Lumo BodyTech, Inc
8 patents
What this shows Lumo holds 8 patents at rank #32,380, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Lumo
By rank, the assignees closest to #32,380 in granted patent volume.
- Louver-Lite Limited #32,376 · 8 patents
- LucasE3, L.C. #32,377 · 8 patents
- Lucerno Dynamics, LLC #32,378 · 8 patents
- Lucida Research LLC #32,379 · 8 patents
- Lundbeck Pharmaceuticals Italy S.P.A. #32,381 · 8 patents
- Lutz Pumpen GmbH #32,382 · 8 patents
- Luxer Corporation #32,383 · 8 patents
- M Group, Inc. #32,384 · 8 patents
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in Lumo's primary technology class.
- Covidien LP 5,709 in class
- Koniniklijke Philips N.V. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag GmbH International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- DePuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
Lumo's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
25 15th percentile higher than 15% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 25.0% |
| 2016 | 2 | 25.0% |
| 2017 | 2 | 25.0% |
| 2018 | 2 | 25.0% |
Which technologies does Lumo BodyTech, Inc patent most?
Top 4 of 4 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Lumo BodyTech, Inc's patent record in context - here's where to go next.
- Lumo BodyTech, Inc's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
- Ranked #32,385 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Lumo BodyTech, Inc against Louver-Lite Limited, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 24.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.